betagenon AB Related News
AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney...
The high and increasing unmet patient need in diabetic kidney disease demands new drugs. Betagenon AB has the answer.
Globally, approximately 40% of Type 2...